Cargando…
Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1
The long-chain fatty acid receptor FFAR1/GPR40 binds agonists in both an interhelical site between the extracellular segments of transmembrane helix (TM)-III and TM-IV and a lipid-exposed groove between the intracellular segments of these helices. Molecular dynamics simulations of FFAR1 with agonist...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452680/ https://www.ncbi.nlm.nih.gov/pubmed/30872479 http://dx.doi.org/10.1073/pnas.1811066116 |
_version_ | 1783409332800454656 |
---|---|
author | Lückmann, Michael Trauelsen, Mette Bentsen, Marie A. Nissen, Tinne A. D. Martins, Joao Fallah, Zohreh Nygaard, Mads M. Papaleo, Elena Lindorff-Larsen, Kresten Schwartz, Thue W. Frimurer, Thomas M. |
author_facet | Lückmann, Michael Trauelsen, Mette Bentsen, Marie A. Nissen, Tinne A. D. Martins, Joao Fallah, Zohreh Nygaard, Mads M. Papaleo, Elena Lindorff-Larsen, Kresten Schwartz, Thue W. Frimurer, Thomas M. |
author_sort | Lückmann, Michael |
collection | PubMed |
description | The long-chain fatty acid receptor FFAR1/GPR40 binds agonists in both an interhelical site between the extracellular segments of transmembrane helix (TM)-III and TM-IV and a lipid-exposed groove between the intracellular segments of these helices. Molecular dynamics simulations of FFAR1 with agonist removed demonstrated a major rearrangement of the polar and charged anchor point residues for the carboxylic acid moiety of the agonist in the interhelical site, which was associated with closure of a neighboring, solvent-exposed pocket between the extracellular poles of TM-I, TM-II, and TM-VII. A synthetic compound designed to bind in this pocket, and thereby prevent its closure, was identified through structure-based virtual screening and shown to function both as an agonist and as an allosteric modulator of receptor activation. This discovery of an allosteric agonist for a previously unexploited, dynamic pocket in FFAR1 demonstrates both the power of including molecular dynamics in the drug discovery process and that this specific, clinically proven, but difficult, antidiabetes target can be addressed by chemotypes different from existing ligands. |
format | Online Article Text |
id | pubmed-6452680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | National Academy of Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-64526802019-04-11 Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1 Lückmann, Michael Trauelsen, Mette Bentsen, Marie A. Nissen, Tinne A. D. Martins, Joao Fallah, Zohreh Nygaard, Mads M. Papaleo, Elena Lindorff-Larsen, Kresten Schwartz, Thue W. Frimurer, Thomas M. Proc Natl Acad Sci U S A Biological Sciences The long-chain fatty acid receptor FFAR1/GPR40 binds agonists in both an interhelical site between the extracellular segments of transmembrane helix (TM)-III and TM-IV and a lipid-exposed groove between the intracellular segments of these helices. Molecular dynamics simulations of FFAR1 with agonist removed demonstrated a major rearrangement of the polar and charged anchor point residues for the carboxylic acid moiety of the agonist in the interhelical site, which was associated with closure of a neighboring, solvent-exposed pocket between the extracellular poles of TM-I, TM-II, and TM-VII. A synthetic compound designed to bind in this pocket, and thereby prevent its closure, was identified through structure-based virtual screening and shown to function both as an agonist and as an allosteric modulator of receptor activation. This discovery of an allosteric agonist for a previously unexploited, dynamic pocket in FFAR1 demonstrates both the power of including molecular dynamics in the drug discovery process and that this specific, clinically proven, but difficult, antidiabetes target can be addressed by chemotypes different from existing ligands. National Academy of Sciences 2019-04-02 2019-03-14 /pmc/articles/PMC6452680/ /pubmed/30872479 http://dx.doi.org/10.1073/pnas.1811066116 Text en Copyright © 2019 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/ This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Biological Sciences Lückmann, Michael Trauelsen, Mette Bentsen, Marie A. Nissen, Tinne A. D. Martins, Joao Fallah, Zohreh Nygaard, Mads M. Papaleo, Elena Lindorff-Larsen, Kresten Schwartz, Thue W. Frimurer, Thomas M. Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1 |
title | Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1 |
title_full | Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1 |
title_fullStr | Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1 |
title_full_unstemmed | Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1 |
title_short | Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1 |
title_sort | molecular dynamics-guided discovery of an ago-allosteric modulator for gpr40/ffar1 |
topic | Biological Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452680/ https://www.ncbi.nlm.nih.gov/pubmed/30872479 http://dx.doi.org/10.1073/pnas.1811066116 |
work_keys_str_mv | AT luckmannmichael moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT trauelsenmette moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT bentsenmariea moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT nissentinnead moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT martinsjoao moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT fallahzohreh moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT nygaardmadsm moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT papaleoelena moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT lindorfflarsenkresten moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT schwartzthuew moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 AT frimurerthomasm moleculardynamicsguideddiscoveryofanagoallostericmodulatorforgpr40ffar1 |